Cavion, Inc. clinical trials
Acquired by Jazz Pharmaceuticals, 2019 · source ↗
The registry lists 2 studies whose lead sponsor is Cavion, Inc.. 0 are recruiting or about to start. Per ClinicalTrials.gov, last updated Jul 24, 2019.
Before and after it joined Jazz Pharmaceuticals
- First submitted before Cavion, Inc. became part of Jazz Pharmaceuticals
- 2
- First submitted after Cavion, Inc. became part of Jazz Pharmaceuticals
- 0
- Unclear, or no submission date
- 0
By the date each study was first submitted to the registry. The registry lists today's sponsor name and keeps no history, so this says when a study was filed, not who filed it.
Registry sponsor names on this page
- Cavion, Inc.2 studies
Something wrong with this grouping? Tell us on the Jazz Pharmaceuticals page.
Studies
Recruiting first, then most recently updated. Showing 2 of 2. All Jazz Pharmaceuticals studies →
- TAU-2014-1: Mibefradil and Hypofractionated Re-Irradiation Therapy in Recurrent GBMCompletedNCT02202993Phase 1
Sponsor listed in the registry: Cavion, Inc. · First submitted before Cavion, Inc. became part of Jazz Pharmaceuticals
- Safety Study of Mibefradil When Given Four Times a Day in Healthy VolunteersCompletedNCT01550458Phase 1
Sponsor listed in the registry: Cavion, Inc. · First submitted before Cavion, Inc. became part of Jazz Pharmaceuticals